Grant: Engage Grants Program
Université de Montréal
$25,000.00
Antibacterial activity of silver nanoparticles towards oral and wound bacteria embedded in biofilms
EF 2018-19
Résumé
Part of the difficulty in treating organisms for bacterial infection is that the bacteria are often embedded within*biofilms, which are complex superstructures in which bacterial microcolonies are dispersed in a matrix of*extracellular polymeric substances, lipids, and metabolites. The development of drugs and molecules that can*efficiently be transported across the complex biofilm matrix is essential in order to prepare effect treatments.*Given the complexity of the biofilms and the development of multidrug resistance, non-traditional antibacterial*agents are of emerging interest for the treatment of pathogenic microorganisms. In this context, SK Nano are*producing novel nanomaterials as a cost-effective alternative to the traditional anti-bacterials. The*nanoparticles have numerous projected applications in antibacterial products, which gives them great potential*for commercialization related to wound care, dermatology, veterinary diseases and oral health problems. Using*state-of-the art techniques that are available in our lab (single particle inductively coupled plasma spectroscopy,*SP-ICPMS; dynamic light scattering, DLS; analytical ultracentrifugation, AUC and transmission electron*microscopy, TEM), we will first precisely characterize novel Ag nanomaterials with different sizes, shapes and*surface coatings are being synthesized by SK Nano. In a second step, anti-bacterial properties of AgNPs (three*different sizes, three different forms, three different surface coatings) will be quantified using confocal*scanning laser microscopy (CSLM). Diffusion of the nanoparticles within the bacterial biofilms will be*evaluated by fluorescence correlation spectroscopy. The project will enable us to better understand*structure-function relationships relating the properties of the novel materials with their biological function.*Such information will both further our mechanistic understanding of these products and allow SK Nano to*better design future products with appropriate antibacterial activity.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
530267-2018
Name nom
Wilkinson, Kevin
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
1
Nb partie
1
Application title
Antibacterial activity of silver nanoparticles towards oral and wound bacteria embedded in biofilms
Keyword
NSERC
Application summary
Part of the difficulty in treating organisms for bacterial infection is that the bacteria are often embedded within*biofilms, which are complex superstructures in which bacterial microcolonies are dispersed in a matrix of*extracellular polymeric substances, lipids, and metabolites. The development of drugs and molecules that can*efficiently be transported across the complex biofilm matrix is essential in order to prepare effect treatments.*Given the complexity of the biofilms and the development of multidrug resistance, non-traditional antibacterial*agents are of emerging interest for the treatment of pathogenic microorganisms. In this context, SK Nano are*producing novel nanomaterials as a cost-effective alternative to the traditional anti-bacterials. The*nanoparticles have numerous projected applications in antibacterial products, which gives them great potential*for commercialization related to wound care, dermatology, veterinary diseases and oral health problems. Using*state-of-the art techniques that are available in our lab (single particle inductively coupled plasma spectroscopy,*SP-ICPMS; dynamic light scattering, DLS; analytical ultracentrifugation, AUC and transmission electron*microscopy, TEM), we will first precisely characterize novel Ag nanomaterials with different sizes, shapes and*surface coatings are being synthesized by SK Nano. In a second step, anti-bacterial properties of AgNPs (three*different sizes, three different forms, three different surface coatings) will be quantified using confocal*scanning laser microscopy (CSLM). Diffusion of the nanoparticles within the bacterial biofilms will be*evaluated by fluorescence correlation spectroscopy. The project will enable us to better understand*structure-function relationships relating the properties of the novel materials with their biological function.*Such information will both further our mechanistic understanding of these products and allow SK Nano to*better design future products with appropriate antibacterial activity.